COURT RULING DELAYS MEDICAID CUTS

Published Online: Friday, February 1, 2008

Community pharmacy won an important year-end victory with the US District Court ruling stopping the Centers for Medicare & Medicaid Services (CMS) from implementing its plan to base Medicaid payments for generic prescription drugs on Average Manufacturer Prices (AMPs).

The CMS ruling was scheduled to take effect January 31, resulting in pharmacists receiving payments as much as 36% lower than what certain drugs cost to acquire, according to the Government Accountability Office.

In the lawsuit against the CMS rule filed by the National Community Pharmacists Association and the National Association of Chain Drug Stores, Judge Royce C. Lamberth found there would be "irreparable harm" to community pharmacies.

For more information, visit www.PharmacyTimes.com/AMP.



Latest Articles
This weekly video program highlights the latest in pharmacy news, product news, and more.
Propranolol is red, digoxin is blue. Your pharmacist’s heart may skip a beat if they get a valentine from you.
Health-system pharmacists can play a critical role in managing drug shortages to prevent medical errors and adverse events.
The White House is asking Congress for more than $1.8 billion in emergency funding to combat the Zika virus, which is creeping into the United States and ravaging some foreign countries.
Latest Issues
$auto_registration$
VSEO N/A